Advanced Immune Therapeutic Strategies (AIT Strategies) is a privately held firm focusing on biomedical research and development with a special interest in immunotherapeutics.
AIT Strategies believes that the immune system in individuals has the capacity to detect and eliminate cancer; however, in most clinical presentations, this capacity has proven to be immobilized or is by-passed by factors induced by the malignancy.
Our goal is to facilitate development of novel cancer therapeutics and synergistic combinations that enhance specific immunity for the potential benefit of all those touched by cancer. It is becoming widely appreciated that redundancy of immune suppressive pathways require that combination approaches will be necessary to successfully mobilize and maintain the anti-tumor immunity in the broadest pool of cancer patients.
We work with multiple technology platforms designed to stimulate specific immunity including monoclonal antibodies, adjuvant and vaccine approaches. We collaborate with academic researchers, clinicians and industry seeking innovative solutions. Several main areas of focus are noted:
2021 AIT Strategies